Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Ming-Yen TsaiDepartment of Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.ORCID 0000-0001-7722-3331
Chung-Kuang LuDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi 613016, Taiwan.
Li-Hsin ShuDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi 613016, Taiwan.
Hung-Te LiuDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi 613016, Taiwan.
Yu-Huei WuDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi 613016, Taiwan.
Yu-Shih LinDepartment of Pharmacy, Chiayi Chang Gung Memorial Hospital, Chiayi 613016, Taiwan.
Yao-Hsu YangDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi 613016, Taiwan.
Wei-Tai ShihDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi 613016, Taiwan.ORCID 0000-0002-4995-5364
I-Yun LeeDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi 613016, Taiwan.
Yu-Heng WuInstitute of Communications Engineering, The National Yang Ming Chiao Tung University, Hsinchu City 300093, Taiwan.
Ching-Yuan WuDepartment of Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi 613016, Taiwan.
Funding
Chiayi Chang Gung Memorial Hospital CMRPG6N0081Chiayi Chang Gung Memorial Hospital CMRPG6N0121National Science and Technology Council (TW) NSTC-112-2320-B-182-021-MY3National Science and Technology Council (TW) NSTC-112-2320-B-182-022-MY3
6 · The paper itself
Abstract
Prostate cancer remains a significant global health challenge, necessitating the development of novel therapeutic approaches. This study investigated the therapeutic potential of the
Indexed as
AntrodiaB7-H1 AntigenDrugs, Chinese HerbalProgrammed Cell Death 1 ReceptorProstatic NeoplasmsAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell Line, TumorCell ProliferationCell SurvivalDisease ProgressionHumansMaleMiceSignal TransductionB7-H1 AntigenCD274 protein, humanDrugs, Chinese HerbalPDCD1 protein, humanProgrammed Cell Death 1 ReceptormacrophagePD-1PD-L1prostate cancerT-cellsXIANZHIFANG formula
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.